Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 12:05 PM
Ignite Modification Date:
2025-12-24 @ 12:05 PM
NCT ID:
NCT00003261
Eligibility Criteria:
DISEASE CHARACTERISTICS:
* Histologically proven HIV-related non-Hodgkin's lymphoma of the CNS
* No systemic lymphoma
PATIENT CHARACTERISTICS:
Age:
* 18 and over
Performance status:
* WHO 0-3
Life expectancy:
* Not specified
Hematopoietic:
* WBC at least 3000/mm\^3
* Platelet count at least 80,000/mm\^3
Hepatic:
* No serious impairment of liver function
Renal:
* No serious impairment of renal function
* Creatinine clearance at least 40 mL/min
Cardiovascular:
* No serious impairment of cardiac function
Neurologic:
* Neurological functional status 0-3
Other:
* No prior or active CNS-opportunistic infections
* No AIDS dementia complex
* No active systemic infections
PRIOR CONCURRENT THERAPY:
* No prior chemotherapy or radiotherapy
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00003261
Study Brief:
Protocol Section:
NCT00003261